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Abstract
Positron Em ission Tomography (PET) is a new tool wi th which to explore the neurobiological
basis if psychiatric illness. PE T permits in-vivo measurement if regional cerebral blood flow,
regional gl ucose metabolism, as well as infirmation about neurochemicals and their receptors. S ince
regional cerebral bloodflow and glucose metabolism reflect ongoing neuronal activity, the neural
bases if different cogniti ve processes and emotional states can be discerned using PET. Findings
from recent studies in schizophrenia, a.ffective disorders, obsessive-compulsi ve disorders, anxiety
disorders, and dementia are reviewed with a special emphasis on how thesefi ndings may' be useful in
developing a more comprehensive .framework fir understanding the neurobiological basis if
psychia tric disorders. Th e relationship between PE T and other brain imaging modal ities, the
imminent improvements in PET technology, as well asfuture directions ifresearch are discussed.
II'.'TRO DU CTI O N
[eurobiological fact ors a re important det erminant s of psychi at r ic illness. How-
ever , how th ese neu robiological factors lead to t he observed psychi at ric symptoms is
far from clear. Invest iga t ions us ing indirect (e.g . plasma , urine a nd cerebrospinal
fluid neuroch e mist ry, receptor expre ssion in periphera l sites ) a nd direct indi ces (e.g.
CT sca ns , MRI sca ns, su rface elec t ro physiolog ica l recordings, neuroendocri ne cha l-
lenges) have confirme d th e ass ociation between neurobi ological fac tors and psychi at-
ric illn esses . However, in the ab sence of a com pre he ns ive fram ework for understa nd-
ing behavior and emotion in th e con te x t of br ain fun ct ion , th ese findings remain
iso la ted em pir ica l facts . T he challe nge now is to unite th ese facts in to a useful
theore tica l fram ework-on e which will permi t a pathophysiologi ca l understandi ng of
psychia tric illness, a nd a rat ional ba sis for th e treatment of th ese di sorders. Herein
lies the prom ise of PET.
PET offe rs th e opportuni ty to develop a unifi ed th eory rela t ing emotions and
beh avior to neurophysio logical a nd neuroch emical eve nts in a neu roa na tomical
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con te xt. T o illustrate, it is kn own that ce r ta in foca l lesion s (e.g . left frontal strokes) ,
or ce r ta in syste mic neuroch emical alteration s (e.g. sym pa tho mim et ic withdrawal) , or
pr ofound psych osocial st ress (e .g. dea th of a spouse) may a ll lead to a dep ressive
synd ro me . Furthermore, a ll th e above cas es may respond to treatment wit h a
se ro ton in-specific reuptake inhibitor (SSRI) a n t ide pressan t. PET offers, at least in
principl e, th e oppo r tun ity to uni fy th ese isolated fac ts. By e lucidat ing th e network of
br ain region s subse rving mood ( I), it may help us to und e rsta nd why left frontal
st ro kes are particularly cruc ia l in inducin g depressive sym pto ms. By specifyin g how
cog nitio n and stress influence this network of regions, one may understa nd how
situat iona l fact ors may induce depression. By unraveling th e ro le of neurotran smit-
ters in th e modulation of this 'mood network ' , one may understand how sym pa thomi-
metic withdrawal induces depression and SSRIs treat it (2).
In this article, we review PET as it is relevant to th e field of psych iatry. The first
section will provid e th e read ers with a glim pse into th e ph ysical principl es a nd the
instrumentation as relevant for th e int erpretation of PET stud ies . T he second section
will describe th e ph ysio logica l param et ers th at ca n be measured usin g PET. T he third
section reviews how PET stud ies have con t r ibu te d to ou r und ers tanding of variou s
psychi atric illn esses. Fin all y, we ou t line th e relation shi p of PET to other imaging
modaliti es and th e future technical a nd expe rime ntal improvements which may be
important from th e persp ective of psychi at ry.
HOW IS PET SCANNING DONE?
PET scanning depends up on th e visualiza t ion of ra dio labelled tracers introduced
into th e body. There are two major com po ne n ts to a PET progra m- radiochemist ry
and imaging. The acc ount below is intentionally brief-for a mo re t horou gh account
th e reade r is referred to more compre he nsive sources (3-5) .
Radiochemistry
The tracers use d for PET a re specia lly syn thes ized mo lecu les which contain a
positron-emitting isot op e. Positron-emit ting isot op es of common clements like ca r-
bon , oxyge n, nit rogen a nd fluoride (C, 0 , Nand F resp ecti vely) are pr eferred since
thes e elements naturally occur in a wide variety of biologica lly relevant mol ecul es.
These isot op es have sho r t h al f-li~es (IIC -20 minu tes , 150 -2 minu tes , 18F_110 minut es)
whi ch necessitates a cyclo t ro n fac ility, which ge ne rates th e isot op es, eit her on-sit e or
near th e scanning facility. Once the isotope is produced , it is incorpora ted int o the
mo lec ule of int erest (e .g . 150 is incorpo ra ted in water for blood flow stud ies, and may
a lso be inhaled in a gaseous form; 18F is a ttached to deoxyglucos e for glu cose
met ab ol ism s tudies; IIC is incorporat ed in to raclop rid e, res ult ing in "C-r aclopride,
which binds to dopam ine D2 recept ors). This process of incorporating th e isot op e into
t he t racer agen t is pa rticul arly deman ding since high levels of che mica l purity and
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The sca n ning is done with the su bjec t lyin g horizont all y. T he t race r is adminis-
te red via an inj ection or, if gase ous, via inhalation. The a mo unt of radioact ivity
ad m iniste re d, the time of ad m inis t ratio n, a nd th e durat ion of uptake all vary
depending upon the exac t nature of th e trace r a nd the pu rpose of th e study. As th e
tracer undergoes rapid decay it e m its positrons . The positron , a posi t ive ly cha rge d
particle , travels a sho r t di st ance (less than 3 m m ) in th e t issu e a nd th en com bines
with an elect ro n. This com bina tio n leads to th e ge nerat io n of two 5 11 keY ph ot on s
which travel in diam etrica lly opposit e directi on s. The ring of high -sensi t ivity de tec-
tors surro unding th e head (the ca mera) d et ect s th ese ph otons. As the two ph ot on s
e mitted fro m a single positron-el ectron co m binat ion, travel ing in diametrically
opposite directions, s t r ike tw o di ametrically oppos ite d et ect ors, a 'coinc ide nce eve n t'
is recorded. The coinc ide nce eve n t is th e building block of the PET image. Thousands
of suc h co inc idence eve n ts a re recorded during each scan and are used to reconstruct
the image of th e tracer di stribution in th e head . This reco ns truc te d im age const it u tes
the PET sca n . With kn owled ge of the a mount of tracer inj ected , and its di stribu tion
within the different bod y co m par t men ts, th e ac q uire d image can be conve rted into
quantitative physio logica l data . For exam ple, a PET im age obtained with Iluoro-
d eoxyglucose as a tracer ca n be co nverted into a me tabolic image whi ch es t ima tes
region al brain m etaboli sm in terms of milligrams of glucose me tabolized per 100 gm
of tissue per minute in different part s of th e br ain . Thus, PET 1I0t only images th e
functioning of the brain , it a lso m easures it (6) .
WHAT CAN BE MEASURED WITH PET?
Studies don e with PET in the last d ecade ca n be bro adl y d ivid ed into three typ es:
cerebral blood flow s tudies ; g lucose me tabo lism st udies and neurochemical stud ies.
Cerebral B lood Flow (rCBF) Studies
The tracer used for rCBF im agin g is usu all y wa te r co n tam mg 150, inj ect ed
intraven ou sly. The sca n ning begins im m edi a tely after the inj ection and last s 60- 120
seconds. 150 has a sho r t hal f-li fe a nd th e t racer decays a lmos t com ple te ly within 10
minut es of inj ection. This a llows th e procedure to be re peated u p to 12 tim es in a
single session (7) . rCBF close ly reflects region al neurona l activity (8) , and hen ce, by
repeating scans while the subject is e ngage d in diffe re nt tasks, and by com pa r ing th e
brain regions ac tiva te d in th e different tasks, one ca n discern t he brai n regions
involved in speci fic cogni tive opera t ions (9- 11). In a prot o typical application of thi s
st ra tegy, Pe te rsen a nd co lleagues (10) scanned subjec ts d ur ing three different
cognit ive task s-passive viewi ng of present ed words, o ra l repet it ion of pr esent ed
words, a nd ge ne ra t ion of verbs associated wi th the present ed wo rds. By com pa r ing
t he rCBF scans obtaine d during t he d ifferent tasks t hey were able to delineat e a reas
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of the brain whi ch were involved in th e visu al recognition of words, in th e production
of sp eech, and in th e act of semantic association (10).
Cerebral Glu cose Metabolism (rCM Glu) S tudies
The tracer, 18F-fluo ro-deoxyglucose (FDG), is tak en up by th e tissues in a
manner simila r to naturally occur ring glucose, but once insid e th e ce ll, FDG does not
undergo further met abolism and is trapped (12 ). The tracer is inj ect ed int ravenously,
a nd is tak en up by th e brain over th e next 45-60 minut es. Tracer 'uptake' is
proportion al to th e rat e of glucose met ab olism in a given region and reaches
eq uilibr ium in 45-60 minut es. Once eq uilibr ium is reach ed the scanning begin s and
may require 15 to 30 minutes to acq uire a high-resolu tion image (12). An important
di fference bet ween a rCBF a nd a rCMGlu PET sca n is th a t the form er refl ects brain
activit y ove r 60- 90 seconds wh ereas th e latter reflect s ac tivity over 45-60 minutes. In
add it ion, 18F has a much longer half-life, and th erefore th e FD G scans cannot be
repeated within a single session. Since 150-water scan s reflect bra in activity over
bri efer epoc hs and ca n be rep eat ed multiple tim es wit hin a sess ion , t hese sca ns are
th e pr eferred m easure for com pa ring neural acti vity in di fferen t cog ni tive, e mo tiona l
or se nsori-mo tor tasks ( 13).
Neurochemical S tudies
These studies use specific ligands to det ermine th e conce n t ra tion a nd distribu-
tion of receptors, neurotran smitters, a nd othe r neuroch emicals within th e br ain
( 14,15). For exa m ple, raclopride, a n a n tipsycho t ic which bin ds to th e dopamine D2
receptor is frequently used. IIC lab eled raclopride ca n be used to visu a lize the level of
D2 dopamine receptor s in th e human st ria t um, a nd to com pa re th e level of th ese
receptors in th e st ria tum of patients with schizo phrenia to th ose of normal con t rols
(16-18). These studies involv e the synthesis of a positron-emitt er eIC or 18F or 76Br),
incorporation of th e isotope into th e tracer mol ecul e, inj ecti on of th e tra cer, PET
sca nning, and finall y, application of mathematical mod els to convert th e image into
qu antitative es timates of th e conce n t ra tion of th e receptor or neuroch emica l (19,20).
As newer ligands are being syn t hes ized more and mor e recept or s an d neuro t ra nsmit-
ters a re becoming accessible to in-vivo measurement (2 1).
SAFETY
The radiation exposure from a PET scan is com pa rable th at of ot her diagnostic
procedures used in nuclear medi cin e, a nd th erefore is easily defensible in patients
who a re receiving direct ben efit from th e investigation. The issu e is more complex
wh en th ese techniques are used in normal volunt eers or in research studies whe re
th ere is no direct ben efit to th e patient. The radiation ex pos ure fro m a PET scan is
det ermined by th e nature of th e tracer, th e amount of radi oactive mat erial adminis-
tered, route of administration, a nd th e total number of scans. As a br oad ge neraliza-
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tion, th e ex pos ure may vary fro m a fifth to nearly double of wh at th e norm al
population receives from background radi ation so urces wit hin a year. In keeping with
this, most research ce n te rs limit th e number of t imes a normal volunt eer can
particip at e in PET ex pe riments a nd th e number of scans a volunteer ca n undergo in a
sing le study.
PET STUDIES OF RELEVANCE TO CLINICAL PSYCHIATR Y
Schizophrenia
The most end uring PET finding in schizo phrenia is th a t of frontal dysfunction-
the pioneering studies by Buch sbau m et al. report ed " frontal hypome tabolism"
(22-25) ; a finding whi ch ha s since been observed by most (26-28) , though not all
gro ups (29,30). C leg ho rn et a l. (31), on th e othe r hand, report a relative front al
hyper-m et ab olism. PET sca ns of patients have been compared to con t rols whil e both
were undertaking a smoot h-purs uit eye- t racking task (32,33), and whi le performing
tasks requiring sus taine d a t te n tion (25,3 4,35); both representing tasks on which
patients with schizophrenia typically show impaired performa nce. T ask-based com-
parison s accen tua te th e resting-st ate differen ces bet ween norma ls a nd patients in
th e front al lob es (25,32-35) sugges ting that not only is there a frontal dysfunction a t
rest , but th at th e respon se of th e frontal lob e to the task demands is also deficient in
patients with schizophre n ia (36-38). In addit ion to invest iga tions of th e frontal lobe ,
th e role of th e temporal lob e (24,39-41 ) , pari et al lobe (40 ,42) , and hemispheri c
asy m me try have been eva luate d usin g PET (43,44) though th e PET evide nce for
impairment in th ese reg ions is less convergen t (45) .
Studies have soug h t to cor re late clinical sym pto ms to regional brain abnormali-
ti es (27,46). It appears th at the onse t of sym pto ms may be associat ed with frontal
hyper-functi on (31) , whil e wit h chro nicity of sym ptoms and neuroleptic treatment
th e picture may cha nge to one of front al hypom et ab olism (27,3 1,32) . C leghorn and
colleagues (47) com pared patients who were ac t ively hall ucin a t ing to those who were
not and found th at pat ients with ac t ive hallucin ation s had significa nt ly lower
m et aboli sm in th e auditory a nd Wernicke 's a rea a nd a high er me tabo lism in Broca's
a rea. Liddle and colleagues (48,49) report a correlation between psychomotor
poverty and left dorso-Iateral pr efrontal co r tex abnormaliti es, con ceptual disorgani-
zation and a nterior cing ula te region abno rmalities, and hallucina tions and delu sion s
a nd medi al temporal cor te x abnormality. Relating ph en omenology to abnormalities
in d iscr et e brain syste ms raises th e possibility of a brai n-based un derstanding of th e
different syndromes and sub-synd romes of this complex illn ess.
The dop amine hypothesis of sch izophrenia is one of t he most en during neuro-
che mica l hypotheses of sch izophre nia. H owever, dop amine receptor studies using
PET have yie lde d conflict ing findings (50) . Won g an d colleagues (5 1-53) report ed a
2.5-fold incr ease in th e dopamine D2 receptors in th e ca uda te-putamen of patients
with schizophrenia using IIC-N-m ethylspiperone as a ligand. In cont rast , Farde
(54,55) and Heital a (I 8) usin g IIC- ra clo pride as a ligan d , a nd Martinot (56) usin g
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76Br-bromolisuride , fail ed to find this incr ease. Differen ces in pa t ien t selection,
differen ces in ligand charac te r ist ics, a nd differen ces in th e mathematical modeling of
th e data have been su ggest ed as possibl e ca uses for th e observed differences in results
(57). Studies with newer ligands will be required before t he issue of D2 dopamine
receptors in sch izophrenia is concl us ive ly resolved (52,55,58).
There is gre a te r conve rge nce, on th e othe r hand, among studies investigating
th e relationship between D2 receptor binding a nd neu rolept ic treatment. The
percent occ upa ncy of th e dopamine receptors in th e st ria tum is closely related to
plasm a neuroleptic levels, though cha nges in receptor occupancy lag behind th e
changes in plasm a levels (59- 61). At th e usual clinica l dose, typ ica l neurolept ics
occupy 70%-85% of th e available D2 receptors, a n effec t tha t is ac hieved, in most
cases, a t doses eq uiva lent to abo ut 150 mg of chlorpro mazine (62-66) . T he atypica l
neuroleptic clozapine, on th e other hand, shows a lower occupancy of D2 receptors
(30- 50%) and a higher occupancy of D) and possibl y S2 receptor s (62-67). Receptor
occupancy, beyond a certain threshold, does not seem to incr ease th erapeu tic effects
but do es tend to incr eas e th e level of ex t ra pyra m idal side-e ffec ts (68-7 1). Taken
together th e evidence suggests th at with typic al neuroleptics, a ce r tai n level of D2
receptor occupancy (70% or greater) is necessary, but may not be sufficient for a
th erapeutic effec t. In addition to blocking th e receptors, neu rol eptics increase
met ab olism in th e ca uda te-puta me n (30,40,72-75). At pr esent th e relevance of th is
finding is not clear. However, as th e rol e of th e st r ia tum in cog nit ion is unraveled
further, it may become possibl e to underst and th e mechanism of neuroleptic
medi cations in terms of th eir neu romodulat ory effec t on the stria tum (75).
These initial st ud ies in schizo phre n ia have offered promising leads. First, th ere
is st ro ng evide nce for fr ontal dysfuncti on in schizophre nia , both at rest and whil e
engaged in specific tasks; othe r co r t ica l a nd subco rt ica l regions may also be invo lved .
Second, gro ups of sym ptoms ca n be related to a dysfuncti on of spec ific brain regions.
Third , neu rol eptic d ru gs produ ce significa n t changes in brain me tabolism in th e
st ria tum via th e occupa ncy of dop am ine receptors. Fourth, a high level of dopamine
D2 receptor occupancy is necessary for clinical resp on se, bu t is not sufficient by itself.
Fifth, th e differen ces in th e clinica l profile of typical vers us a typica l neu rol eptics may
be relat ed to th e differen ces in th e occupa ncy of th e D2 a nd D ) a nd possibly S2
receptors. These findings are preliminary, but th ey offer th e hop e of developing a
com pre he nsive underst anding of th e pathophysiology of schizophrenia an d a rat ional
appr oach to its treatment.
AJfective Disorders
PET has made possible th e study of th e neuroan atomical pa th ways mod ula t ing
mood. Pardo and colleagues have reported th e involvement of t he inferior fronta l
co r te x in se lf-ind uce d dysphori a in normal subjects (I ). In pa t ien ts, depress ive
sym ptoms a re associa te d with a hypo-p erfusion a nd hypo-m et ab olism in the prefron-
tal cor te x (6,76-80). It is unclear if this defect is simila r to th at seen in schizophrenia
(81); it has recently been suggested th at pr efrontal hypo-met abolism may reAect
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psych om ot or poverty, a nd th a t this may be the reason for prefrontal hypo-
met ab olism bein g observed in both schizophre nia a nd depression (82). Pr efrontal
cor te x hypo-m et ab olism see ms to be correlated with symptom severity and a resolu-
t ion of clinica l sym pto ms is acco mpanied with a t re nd towards normalization of thi s
defect (78,83 ,84). In addition to th e fron tal hypo-m etabolism , s tud ies have re ported
an involve men t of t he ca uda te-p utamen (85) as well as limbic structures in depr es-
sion (6,80) .
Previous stud ies investi gating th e neu roch emical cha nges accompa nying depr es-
sion had to infer changes in th e brain via peripheral measures suc h as receptors on
peripheral ce lls or the neu ro transmitter metabolites measured in th e ce re bros pina l
fluid , plasma a nd urine . PET mak es possibl e direct , in- vivo measures. Kishimot o a nd
colleagues (86), usin g radi olab ell ed a mino ac ids, report ed a signifi cant decr ease in
th e a mi no ac id pool in pat ient s with depression a nd a significant increas e in patients
wit h mania. Agr en a nd colleagues (87) re po rted a decr eased transportation of
"C-L-5-hydroxytryptopha n ac ross the blood-brain barrier in pa tien ts with depres-
sion. Us ing lIC-N-me t hylspiperone (lIC -NMSP); a ligand which binds to th e dopa-
mine D2 and se roto nin S2 rece ptors (88), Mayberg a nd colleagues (89) rep ort that
after unil ateral st ro kes, IIC-NMSP binding negat ively corre la te d with th e degr ee of
depressive sympto ms. This suggests that a decr ease in se ro tonin S2 receptor nu mb er
or an inabili ty to up- regul a te S2 rece ptors in the ipsilat eral hemisphere a fter a stroke
may be associa te d with the symptoms of depression.
T hu s, metabolic PET st ud ies in dep ression implicat e th e pr efrontal cortex, th e
caudate -pu ta men, and limbic structures as candidat e st ruc tures subse rving mood
( 1,6,80). T hese find ings help explain , a t least in part, th e incr eased pr open sit y for
developing depression secondary to stroke involving th e front al cortex, Parkinson 's
disease a nd H untington 's disease. T he neurochemical a nd neuroreceptor stu dies
using PET in de pression have demonstrated the potential of in-vivo study, but ther e
are few convergent or re plicated find ings. What is ne ed ed now a re syste matic stu d ies
which on th e one hand identify t he ne uronal and neuroch emical cor relates of
depressive sym pto ms, a nd on the other hand de lineate th e neuroch emical effects of
a nt ide pressan ts which are crucial for th e resolut ion of mood symptoms.
ObsessiveCompulsiveDisorder (OCD)
In a se ries of pion eering st ud ies Baxter a nd colleagues descri bed an elevation of .
met abolism in the right orbital gyrus a nd th e ca udate nu cleu s in OCD (90,9 1).
Subse que nt stud ies by Baxt er a nd colleague s and by other groups with more ca refully
se lec te d drug-free non-depressed O CD patients confirmed this finding (90-93).
C linica l improvement, whether du e to ph a r macological treat ment (fluox etine and
clomipramine) or beh avior th erapy is associa ted with a normalization of th e st ria ta l
hyper-m et ab olism (93-95) .
These find ings suggest th a t sym ptoms in O CD resu lt from the gen eration of
se lf-sus taining, improperl y inhibited , positive feed back loops of motor and cogni t ive
ac tivity in frontal-striat a l/limbic-th al a mic circui ts (96) . In a symptom induction
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study, Rauch a nd co lleagues (97) scanned pa ti en ts with O CD whi le in an asymptom -
a tic sta te a nd subse q ue n t ly whil e experienci ng expe rimentally-ind uce d obsessive-
com pulsive sym pto ms. The sym pto ms were associated with an increased rCBF in t he
front al-striatal-limbic circ uit providing suppo rt for th e above described model (97) . It
is remarkabl e that with th e advent of fun ctional im agin g, in-vivo evide nce is now
ava ilable to identify a neurobiological ba sis for a n illn ess wh ich un til recently was
cons ide re d a protot ypical 'func t ional neurosis'. This does not sugges t tha t psychody-
namic principl es a re supe rfluo us, but it does sugges t th a t th e d ichot om y between
fun ctional a nd orga nic illn esses may no lon ger be ten abl e. In fact, psychodynamic a nd
biological expla na tions may be two com plime nta ry levels of abs traction with which to
understand th e symptoms of OCD. Each fram ework may offer un iqu e insights and
unique treatments.
A nxiery Disorders
Anxiet y dis orders are th e mos t com mo n of psych iat r ic d isorders, a nd ye t little is
known abo u t the neuroanat omical basis of a nxiety (98) . Ini t ial PET studies of
patients with panic dis order sugge ste d that a t least a subse t of them showed
metabolic asymmetry in th e hippocampal region (99). T o tes t th is hypothesis,
Reiman and colleagues (100-102) induced pani c a ttacks in susceptible subjects
during th e PET scan it self and found sign ifican t increases in the rC BF in th e
temporal poles, in sul ar cor te x, cla us t rum and puta men. However , th ese findi ngs
have subseq ue ntly been qu estion ed and othe r groups fa il to find the sa me result s
( 103).
Dementias
Although no pathognomonic pattern of br ain dysfunct ion d iagn osti c of dem entia
has eme rge d , patients with Alzh eimer's di sease do show a rela tive reducti on in
me tabolism in th e front al a nd te m poro-pa rie tal associa t ion areas wh en com pa red to
age-matc he d con t ro ls. There also see ms to be an inverse corre lation between ove ra ll
sym pto ms a nd region al met ab olism ( 104). In add it ion, t he re seems to be a significant
loss in th e serotonergic receptors in front al and temporo-pa rie tal cor t ical regions
(105). The effec ts of th e demen ting illn ess a re hard to di st ingu ish since th ey a re
confounde d by th e effec ts of normal ag ing on metabo lism ( 106, I07) , receptors (88) ,
a nd st ructu ra l a trophy. While a t this ti m e th e clin ical ut ility is limit ed , it is hop ed
th a t with th e a pplica t ion of advance d statis t ica l method s (108) and cog ni t ive-
cha lle nge techniques (109 ) PET could play a n importan t rol e in th e ea rly diagnosis of
dem entia ( 108, II 0) , in differentiating Alzh eimer 's d isease from m ulti- infarct demen -
t ia ( 111- 113), a nd in distingu ish ing dement ia from depression ( 114) a nd ot her
confound ing illnesses ( I I I) .
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PET provides th e information abou t brain fun ction. CT a nd th e MRl techniqu es ,
on th e other hand, provide the neuroanatomical information. The techniques comple-
ment each other, and by co-registe r ing a MRI scan of a given indi vidu al to their PET
scan th e ana tomica l precision of the in terpre ta t ions of th e PET dat a may be
improv ed ( 115). Recen tly, MRI scanners have been used to obtain infor ma t ion about
regional cha nge s in hemoglobin sa tu ra t ion; a technique which provid es in for ma t ion
similar to that obtained from PET rCBF stud ies ( 116- 118). This techniq ue of
" func t iona l MRI" is new, but once sta nda rd ized , offers th e pot ent ial of providing
information reg arding rCBF with grea te r a na tomica l pr ecision a nd no radiation risk .
Nuclear magn etic resonance spectroscop y uses magn etic reson an ce for measuring
th e level of neuroch emical met ab olit es in different region s of the bra in (119) . The
metabolit es measured are different from those assessed usin g PET and therefore th e
two techniq ue s ca n com pleme nt eac h other.
Single photon emission com puted tomography or SPECT is a n im agin g modality
which is fun ctionally simila r to PET . The maj or differen ce between th e two is th e
na ture of the tracer and the degree of spatial resolution . T racers used in PET
imagin g invo lve shor t-lived isotopes of C , N, 0 a nd F. While thi s pe rmits th e
producti on of a wide variet y of biological agen ts, it necessit at es a cyclo tron for th e
producti on of th e tracers. SPECT im agin g, on th e ot her hand, incorpora tes long-lived
isotopes of technetium and iodine. Since th ese ele me n ts do not natu rally occur in a
wid e va rie ty of biologica l che mica ls, it limits th e va rie ty of com po unds whi ch ca n be
produced , but since th e half-life of th e tracers is lon g, th e tracers ca n be pr od uced a t a
remote sit e and shipped to t he ca me ra -site for im aging. The pr esent ge nera tion of
PET ca me ras provide a highe r degree of spa t ia l resolution ; however, wit h increasing
sophisticat ion in SPECT technology this differen ce in resolution is na rrowing. Thus,
PET imaging, du e to th e wider ran ge of ava ila ble liga nds a nd high er resolution, may
be more usefu l as a research tool in th e initial stages of investi gation . SPECT, du e to
it s lower cos t and gre a te r ava ilability, would be th e vehicle for the wider diss emina-
tion of th e useful research a nd clinical a pplica t ions derived from initi al PET studies .
PET AND PSYCHIATRY-WHAT DO ES THE FUTURE HOLD?
The PET technology is undergoing cont inuous improvem ent ; th e in-p lan e
reso lution has reach ed th e th eore t ica l maxim um of about 3 mm . (3,5). PET an d MRI
images can be co-regist ered using a u toma te d software (120-1 22). Aut om at ed met h-
od s a re now becoming avai lable for image a na lysis ( 123-125). In addi tion , new
statistical methods are being develop ed which will permit th e comparison of brain
networks rather than sing le region s (126-130) .
It is now well recognized th at dynamic test s, such as t he ca rd iac stress test a nd
th e glucose tol erance test , a re more se ns it ive a nd spec ific measures of the fun cti onal
status of th e respective ph ysiological syste ms th an baseline measures. Such a p-
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proaches sho uld now be im plemented in th e fie ld of psychi atry using PET. Fo r
exa m ple, rather th an com pa ring schizoph renic pa tients with con t ro ls at rest , pa-
tients shou ld be st ud ied while engaged in cognitive tasks which best d ifferentia te
th em behaviorally from th eir cont ro ls. Thereby , on e would not only ident ify br ain
abnormaliti es, but more usefu lly, understand brain abnormaliti es which a re specifi-
ca lly rela ted to th e fun ct ional deficits shown by th e patients (36,38). Mood stat es a nd
anxie ty levels ca n be modified experime nta lly in safe and ethica l paradi gm s. Standard-
ized "emotio nal challe nges" shou ld be developed and used with PET to delin eate the
ne ural network s which subserve mood ( 1,2,97, 102, 103). Moreover, PET permi ts the
in vivo study of the in teraction of pharmacologica l, cog nit ive, a nd emo tiona l states
(13 1,132) . These approaches could be com bine d and th e behavior al effec ts of drugs
could be understood in terms of their neuroanatom ically spec ific mod ulat ion of
networks. Su ch st ud ies may permit us to develop a com pre he ns ive neurobiological
framewor k of huma n emotion an d behavior as a basis for understanding psychia t ric
illn ess (2) .
The find ings whi ch will emerge using these new techniques and paradigm s, in all
likel ihood , will not accommodate th emselves in our pr esent conce ptua l niches.
Diagnostic syst ems, ou r abi lit y to classify and ca te gorize obs ervabl e ph enom en on , are
th e bedrock of scientific research and serve th e purpose of identifyin g a rela tively
homogenous group of patients who ca n th en be stud ied and with respect to whom
pr ed ict ions ca n be made. As op posed to th e rest of modern medi cin e wh ere nosology
is primarily pathop hysiology-b ased, t he presen t syst em of classification in psychi a try
is bas ed on t he ident ification of a cluster of symptoms. While such diagnostic systems
have and may cont inu e to serve us well clini ca lly, this may not be th e best way to
identi fy homogenous groups of patients for neurobiological research . The real
challe nge th en, will be to go beyond our cur re nt diagnostic const rai n ts a nd look a t th e
symptoms that cu t across syndromes and syndrom es th at cu t ac ross disorders (82).
For exa m ple, the sa me brain syste ms may subserve psychomotor poverty, irrespective
of whe the r th ey are encountered in depression or schizophren ia. On the other ha nd ,
different brain systems may subserve psychomotor poverty and delusions /hallucina-
tions even t ho ugh t hese symptoms are clustered together under th e di agn osis of
sch izophre nia (82) . Thus, brain-based physiological syst ems, in add it ion to ph en om-
enologica l clus tering, may be com e the basis for di agnosing a nd treating psych ia tric
illness (2,36, 133) . PET has opened th e window to th e br ain-the next decad e will
det erm ine if it will change ou r vision of mental illn ess.
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